Stigma surrounding functional neurological disorder (FND) often begins with misunderstanding what the condition actually is. FND involves real, involuntary changes in how the nervous system functions, leading to symptoms such as seizures, weakness, movement problems, sensory changes, or cognitive difficulties, even when standard tests do not show structural damage. Because many people—including some health professionals—still equate “real illness” with visible injury on scans or blood tests, symptoms of FND are sometimes dismissed as exaggerated, “all in the head,” or under the person’s control. This gap between what is happening in the brain and what appears on routine tests feeds a powerful form of stigma that can affect nearly every aspect of a person’s life.
There are several layers of stigma relevant to FND. Public stigma refers to the negative attitudes and stereotypes held by society at large, such as believing that people with FND are faking, seeking attention, or simply stressed and needing to “pull themselves together.” Structural stigma shows up in health care systems, insurance policies, and social services that are not designed to recognize or support FND, leading to limited access to appropriate treatment and difficulty obtaining disability accommodations. Internalized stigma occurs when individuals with FND absorb these negative beliefs and begin to see themselves as weak, unreliable, or to blame for their condition. These layers can interact, amplifying the harm and undermining both mental and physical health.
Historical views of medically unexplained symptoms and the legacy of terms like “hysteria” have fueled ongoing misconceptions. For many years, neurological symptoms that lacked a clear structural explanation were relegated to a poorly understood gray area between neurology and psychiatry. This history contributes to some clinicians still viewing FND as less legitimate than other neurological conditions, or as simply a manifestation of stress or unresolved psychological issues. When patients sense doubt or judgment from professionals, even if nothing overt is said, it reinforces the sense of being disbelieved and intensifies stigma. The lingering impact of these outdated ideas continues to shape public awareness and professional attitudes today.
Stigma is not only social; it directly affects clinical care. People with FND often report long delays in receiving a diagnosis, being sent from specialist to specialist, or having their symptoms attributed solely to anxiety, depression, or personality traits without a thorough neurological assessment. When symptoms are not taken seriously, serious comorbid conditions can be missed, and opportunities for early, effective intervention are lost. In emergency settings, individuals with functional seizures may be labeled as “behavioral” rather than receiving a careful evaluation. Such experiences can discourage people from seeking future medical help, causing them to delay care and worsening health outcomes over time.
Within clinical encounters, stigma frequently appears in the language and tone used by health professionals. Descriptions like “pseudo-seizure,” “non-organic,” or “psychogenic” may be intended as technical terms, but they can sound invalidating and reinforce the idea that symptoms are not real. Dismissive remarks, eye-rolling, or body language that conveys impatience can be as damaging as explicit statements. Poor communication—such as telling someone “there is nothing wrong” after normal imaging, without explaining FND—leaves patients feeling invalidated and confused. When people walk away believing that their symptoms were judged or minimized, trust in the health care system erodes, and adherence to treatment becomes far more difficult.
Beyond the clinical setting, stigma can disrupt relationships at home, work, and school. Friends, family members, colleagues, or teachers may question the authenticity of symptoms, especially if they fluctuate or do not match their expectations of illness. The unpredictable nature of FND—where a person can sometimes perform tasks and at other times be severely limited—can be misinterpreted as inconsistency or manipulation. Employers may see frequent absences or variable performance as a lack of reliability, leading to job loss or stalled careers. Over time, social isolation can grow as people withdraw to avoid judgment, further compounding the emotional and economic impact of the disorder.
Internalized stigma has particularly profound effects on mental health and daily functioning. When individuals repeatedly hear or sense that their symptoms are not believed, they may begin to doubt their own perceptions, question their worth, and feel ashamed of needing help. Some may push themselves beyond safe limits in an effort to prove their symptoms are real, worsening fatigue, pain, or seizure frequency. Others may avoid discussing their condition entirely, fearing ridicule or rejection. This internal conflict increases the risk of depression, anxiety, and suicidal thoughts, and can make it harder to engage with therapies that require openness and collaboration.
Stigma also affects how people understand and manage their own condition. Without accurate information, health literacy about FND remains low, leaving individuals vulnerable to myths and misinformation. Some may believe FND is a sign of moral failure, poor character, or permanent brain damage. Others might assume that nothing can be done, leading to hopelessness and disengagement from treatment. In families, misconceptions can fuel unhelpful dynamics—such as overprotection, criticism, or denial—that ultimately interfere with recovery. When stigma shapes the narrative around FND, it limits the ability of patients and caregivers to make informed decisions and advocate for appropriate care.
Cultural beliefs and societal expectations shape stigma in important ways. In some communities, illnesses without clear biological markers are more easily dismissed or attributed to stress, spiritual causes, or personal weakness. Gender norms and stereotypes may further complicate how FND is perceived—for example, women may be told their symptoms are simply hormonal or emotional, while men may feel additional pressure to hide symptoms to avoid appearing weak. Differences in access to information, language, and culturally sensitive care can intensify these challenges, particularly for marginalized groups who already face discrimination and barriers within health systems.
Stigma extends into policy and resource allocation, influencing the level of funding and institutional support devoted to FND research and services. Conditions that are poorly understood or perceived as less “organic” historically receive less investment, slowing scientific progress and limiting the development of specialized clinics, rehabilitation programs, and community supports. This structural neglect sends a clear message: that FND does not warrant the same seriousness as other neurological disorders. People living with FND feel the consequences when they struggle to find knowledgeable providers, evidence-based treatments, and coordinated care pathways in their region.
Experiencing stigma over time can shape how people with FND present their symptoms and interact with health professionals. Some may minimize or underreport symptoms to avoid negative reactions, making accurate assessment more difficult. Others may overemphasize certain aspects, hoping to convince skeptics of the severity of their condition. These patterns are understandable responses to repeated invalidation, but they can inadvertently reinforce clinician doubts and perpetuate a cycle of mistrust. Recognizing that these dynamics often arise from earlier stigmatizing encounters is essential for interpreting clinical presentations with empathy rather than suspicion.
Understanding stigma in FND also involves recognizing how it interacts with coexisting conditions such as chronic pain, fatigue, mood disorders, or other neurological diagnoses. When people have multiple conditions, stereotypes and biases can stack, leading clinicians or others to view them as “difficult” or “high utilizers” of health care. This can result in fragmented care, where each symptom cluster is addressed separately without a holistic plan. The interplay between symptoms, identity, and stigma can be complex, but ignoring these intersections tends to worsen both physical and psychological suffering.
At its core, stigma surrounding FND is sustained by gaps in knowledge, entrenched myths, and inconsistent messages from health professionals and public institutions. Addressing these issues requires more than just correcting facts; it involves shifting attitudes about what counts as legitimate illness and who deserves care and compassion. When FND is acknowledged as a genuine, diagnosable, and treatable neurological condition—rather than a diagnosis of exclusion or a label of last resort—it becomes easier to see how stigma has distorted perceptions and practices. Recognizing the full scope of this problem is a necessary step toward changing how FND is discussed, diagnosed, and managed across health care and society.
Barriers to accurate diagnosis and health literacy
Barriers to an accurate diagnosis of functional neurological disorder begin well before a person meets a specialist. Many individuals first present in emergency departments or primary care settings where time is limited, tests are prioritized over detailed history-taking, and clinicians may have minimal exposure to FND during training. When brain imaging, blood tests, or EEGs are normal, symptoms can be labeled as “non-neurological” or attributed to stress without a careful explanation of what that means. This tendency to equate “normal tests” with “nothing is wrong” delays a clear diagnosis and reinforces stigma, leaving patients feeling dismissed rather than guided toward appropriate assessment and care.
Diagnostic criteria for FND have evolved significantly, but not all clinicians are aware of these advances. Contemporary approaches emphasize positive clinical signs—such as inconsistency with recognized disease patterns or symptoms that improve with distraction—rather than relying solely on the absence of structural abnormalities. In many settings, however, FND is still treated as a diagnosis of exclusion made only after everything else is ruled out. This outdated approach can lead to prolonged, costly, and often invasive investigations, while therapeutic interventions are postponed. The longer someone goes without a clear diagnosis, the more entrenched anxiety, uncertainty, and mistrust can become, complicating both physical and psychological recovery.
Limited health literacy about FND among health professionals is a major barrier. Neurologists, psychiatrists, emergency physicians, nurses, and allied health providers may receive little formal education on recognizing and managing FND, leaving them uncertain about how to interpret symptoms or what to tell patients. Without a solid framework, some clinicians default to simplistic explanations—such as “this is stress” or “this is psychological”—which fail to reflect the complex interaction between brain, body, and environment. This knowledge gap also makes it harder for teams to coordinate care, as different specialists may hold conflicting views about what FND is and how it should be treated.
Communication challenges within clinical encounters further obstruct accurate diagnosis. When clinicians feel unsure about FND, they may avoid detailed conversations or use vague language such as “functional,” “non-organic,” or “somatization” without clarifying what these terms mean. Patients may leave with the impression that their symptoms are imaginary, voluntary, or a character flaw, even if that was not the clinician’s intention. On the other side, patients who have already experienced disbelief or stigma may be guarded, fearful, or skeptical, making it harder to share a full history. These mutual misunderstandings can derail a collaborative diagnostic process and feed a cycle of mistrust.
Health literacy barriers are not limited to professionals; many patients and families have never heard of FND before they receive the diagnosis. Medical terminology can be confusing, and written materials are often lacking or pitched at a level that is hard to understand. Without clear, accessible explanations, people may search online and encounter outdated or misleading information that frames FND as purely psychological or as a “wastebasket diagnosis.” As a result, individuals may question whether their diagnosis is legitimate, worry they are being dismissed, or assume that nothing effective can be done. Poor health literacy in this context can undermine engagement with treatment from the very beginning.
Social and cultural factors compound these difficulties. In communities where mental health is heavily stigmatized or where physical symptoms are considered the only acceptable expression of distress, a diagnosis that sits at the intersection of neurology and psychiatry can be especially hard to accept. Some cultural beliefs equate invisible illnesses with spiritual causes or personal weakness, making families hesitant to seek care or discuss the condition openly. Language barriers and lack of culturally adapted educational materials intensify the problem, leaving individuals dependent on fragmented information from multiple sources and widening disparities in diagnosis and care.
Structural features of health systems also interfere with timely and accurate diagnosis. Many regions lack specialized FND clinics or coordinated care pathways, so patients are referred from one department to another—neurology, psychiatry, rheumatology, pain clinics—without a single clinician taking overall responsibility. Appointment times are often short, leaving little room for the complex history-taking, examination, and explanation that FND requires. Insurance policies may not cover multidisciplinary programs or extended counseling about the diagnosis, even though these are critical for improving understanding and outcomes. These systemic barriers send an implicit message that FND is not a priority, contributing to both diagnostic delay and persistent stigma.
Coexisting medical and psychiatric conditions make the diagnostic process even more complicated. People with FND often have migraines, chronic pain, fatigue syndromes, anxiety, depression, or a history of trauma. When symptoms overlap, clinicians may focus on one diagnosis and overlook FND, or assume that all symptoms are explained by a single psychological label. This can lead to partial or inaccurate conclusions, such as diagnosing only panic disorder in someone who also has functional seizures. Without training in how FND presents across different symptom clusters, teams may miss positive signs of the disorder and fail to provide a clear, integrative explanation that makes sense to the patient.
Biases and assumptions held by clinicians act as another barrier. Some may unconsciously view patients with fluctuating symptoms or repeated emergency visits as “difficult” or “attention seeking,” which affects the thoroughness of assessments and the tone of interactions. If a patient’s history includes mental health diagnoses, substance use, or previous episodes labeled as “medically unexplained,” clinicians may prematurely conclude that current symptoms are purely psychological, without conducting a careful neurological exam. These shortcuts not only risk misdiagnosis but also erode the patient’s willingness to seek care in the future, further entrenching stigma and limiting opportunities for effective treatment.
Gender, race, and socioeconomic status can shape how symptoms are interpreted and how quickly FND is recognized. Women’s symptoms may be attributed to hormones or emotional instability; men may be expected to “tough it out” and are sometimes taken less seriously when they report fatigue, pain, or non-epileptic seizures. People from racial or ethnic minority groups may face additional prejudice, including assumptions about drug-seeking behavior or poor adherence. Individuals with lower income or limited education may be perceived as less credible historians. These intersecting biases influence which tests are ordered, how explanations are framed, and whether a referral to an FND-informed specialist is made at all.
Another barrier lies in the lack of consistent messaging about FND across different professionals. A neurologist may explain that FND is a disorder of brain function that is potentially reversible, while another clinician describes it as “psychological” or “stress-related,” and yet another tells the person that they simply do not know what is going on. This patchwork of explanations creates confusion, undermines trust, and makes it difficult for patients to form a coherent understanding of their condition. Without a unified approach to communication, individuals may bounce between belief and doubt, or reject the diagnosis altogether, which can delay engagement with targeted therapies that might help.
The health literacy gap is particularly evident when discussing prognosis and treatment. Some clinicians, uncertain about the evidence base, may offer overly pessimistic or overly optimistic messages, such as “there is nothing we can do” or “this will disappear once you reduce stress.” When reality does not match these statements, patients may feel misled and lose confidence in the diagnosis. Clear, balanced information about the range of possible outcomes—emphasizing that improvement is common but may require effort, time, and a multidisciplinary approach—is often missing. Without this nuance, individuals struggle to set realistic expectations, weigh treatment options, or take an active role in their own care.
Barriers to accurate diagnosis and health literacy also arise from the limited availability of reliable, patient-centered educational resources. Many clinic leaflets are brief, technical, or focused on a narrow set of symptoms. Few materials address common questions such as “Why do my symptoms change day to day?” or “How can my brain cause these physical problems?” in simple, nonjudgmental language. When high-quality resources do exist, they may be difficult to access due to paywalls, lack of translation, or limited internet access. This leaves patients and families piecing together information from social media, forums, or anecdotal reports, which can be helpful but also expose them to misinformation, unproven treatments, or narratives that reinforce helplessness.
Time pressure in clinical environments is a persistent obstacle. A thorough FND assessment often requires listening to the patient’s story in detail, observing symptoms over time, and providing a careful explanation of how the diagnosis was made. In many systems, appointment slots are too short to accomplish this, especially when clinicians must also manage documentation, referrals, and other tasks. As a result, explanations are rushed, questions go unanswered, and follow-up is inconsistent. Without sufficient time dedicated to communication, even a correct diagnosis may fail to translate into meaningful health literacy for the patient or their caregivers.
The broader context of public awareness influences every step of the diagnostic journey. When media portrayals of FND and related conditions are inaccurate, sensationalized, or nonexistent, clinicians and patients alike come to the encounter with limited or distorted expectations. A person who has never heard of FND may interpret a new diagnosis as a dismissal, while a clinician who has only encountered the term in passing may feel unprepared to explain it. This mutual uncertainty increases the likelihood of misunderstanding, fuels stigma, and makes it difficult to establish the shared knowledge base necessary for effective collaboration and long-term management.
Strategies for reducing stigma in clinical practice
Reducing stigma in clinical practice begins with the way clinicians think about and talk about functional neurological disorder. Viewing FND as a legitimate, common, and treatable disorder of brain function—not a “wastebasket” diagnosis—sets the tone for every interaction. Clinicians can consciously challenge their own assumptions by asking, “If this were multiple sclerosis, epilepsy, or Parkinson’s disease, how would I speak to this person? How would I document their symptoms?” Bringing this mindset to FND reduces the risk of minimizing complaints, rushing consultations, or framing the diagnosis in a way that blames the patient. Building this perspective often requires targeted training and exposure to current evidence, including contemporary diagnostic criteria and outcome data, so that FND is no longer seen as mysterious or untreatable.
Language is one of the most powerful tools for addressing stigma. Replacing terms that sound dismissive—such as “pseudo-seizures,” “non-organic,” or “psychogenic” used without explanation—with clear and neutral phrases helps people feel taken seriously. For example, describing the condition as “a functional neurological disorder, where the brain is not sending and receiving signals in the usual way” emphasizes that something real and measurable is happening, even if scans are normal. When documenting in medical records, clinicians can avoid labels like “difficult patient” or “frequent attender” and instead focus on observable signs, positive diagnostic features of FND, and the person’s strengths and goals. This shift in wording helps prevent negative attitudes from spreading across teams and reinforces that FND deserves the same respect as other neurological diagnoses.
How the diagnosis is delivered has a major impact on both stigma and health literacy. A structured explanation that links symptoms to known mechanisms, rather than simply stating what the condition is not, can transform how patients understand themselves. Effective communication often includes three elements: clearly naming the diagnosis; explaining how it was made using positive clinical signs; and describing how FND fits into current neuroscience. For example, a clinician might say, “Your exam showed signs that are typical of FND, such as weakness that changes with distraction. This tells us your nervous system is capable of normal movement, but the way signals are being processed is disrupted.” This approach validates the reality of symptoms, provides a coherent explanation, and makes it clear that the diagnosis is based on something the clinician has directly observed.
Allocating adequate time for discussion is essential. When explanations are rushed, people often leave with partial or incorrect impressions, which can reinforce stigma and mistrust. Integrating follow-up visits specifically devoted to education, questions, and care planning can reduce anxiety and improve adherence. Some clinics create a standard “diagnosis visit” where the focus is not on ordering more tests but on detailed conversation, review of written resources, and shared decision-making about treatment. Even in time-pressured environments, small changes—such as scheduling a brief follow-up phone call, providing a direct contact for questions, or coordinating with a nurse or psychologist who can continue the conversation—can markedly improve understanding.
Training whole teams, not just individual specialists, is another key strategy. Emergency physicians, primary care clinicians, nurses, rehabilitation therapists, psychologists, and social workers all encounter people with FND. When only a few team members are familiar with current concepts, mixed messages are inevitable and stigma can easily re-emerge through offhand comments or inconsistent explanations. Interdisciplinary training sessions, case conferences, and joint clinics allow teams to share knowledge, align language, and practice unified messages. Short, targeted teaching modules—covering positive diagnostic signs, basic pathophysiology, and communication strategies—can be integrated into residency programs, continuing education, and staff orientations. Embedding FND content in neurology, psychiatry, and emergency medicine curricula normalizes the condition as a routine part of clinical practice rather than a rare or “exotic” diagnosis.
Clinical pathways and protocols can institutionalize stigma-reducing practices. For example, hospitals can develop standardized care bundles for functional seizures that include medical stabilization, avoidance of unnecessary repeated emergency medications once epileptic seizures have been ruled out, early involvement of FND-informed staff, and a clear plan for follow-up. Written protocols can also specify preferred terminology, recommended patient information materials, and criteria for referral to multidisciplinary FND services. When these elements are embedded into electronic health records—such as templates for FND assessments, diagnostic letters, or discharge summaries—they help ensure that even clinicians with limited prior exposure have a roadmap for respectful, evidence-based care.
Interdisciplinary collaboration in day-to-day practice also reduces stigma. Involving physiotherapists, occupational therapists, speech and language therapists, psychologists, and social workers makes it clear that FND treatment is active and skill-based, rather than limited to “reassurance.” Rehabilitation professionals can use their sessions to reinforce a non-blaming narrative: symptoms are real, changeable, and influenced by patterns in movement, attention, and expectations. Consistent messages across the team—for example, that graded activity, learning symptom management strategies, and addressing triggers can improve function—counter the idea that nothing can be done. When patients see that multiple professionals take their condition seriously and collaborate on a shared plan, their own internalized stigma often decreases.
Written and digital materials tailored to FND play an important role in improving health literacy and decreasing stigma. Clinics can provide brochures or links to reputable websites that explain FND in straightforward, nonjudgmental language and include diagrams, testimonials, and frequently asked questions. These resources can clarify that FND is common, affects people of all backgrounds, and often improves with appropriate care. They can also address myths directly, such as “If tests are normal, the symptoms must be fake” or “FND means I am imagining my problems.” Offering materials in multiple languages and at different reading levels broadens accessibility and signals respect for diverse backgrounds. Encouraging patients to share these resources with family, employers, or schools helps extend accurate information beyond the clinic.
Documentation and communication between clinicians can either perpetuate or reduce stigma. Clear, respectful letters to primary care providers and other specialists that explain the diagnosis, outline the evidence base, and recommend management strategies help prevent future encounters from repeating the cycle of disbelief and unnecessary testing. These letters can emphasize positive findings (“On examination, there were features consistent with functional weakness…”) and include brief educational summaries for colleagues less familiar with FND. Adding standardized phrases that explicitly state the condition is genuine and treatable—for instance, “FND is a common and disabling neurological condition with evidence-based treatment options”—sets expectations for ongoing care and counters dismissive attitudes.
Reflective practice and supervision are valuable tools for addressing implicit bias. Regularly reviewing challenging cases, debriefing after difficult encounters, and inviting feedback from colleagues can help clinicians notice when frustration, skepticism, or burnout might be affecting their behavior. Asking questions such as, “Would I feel differently about this patient if their MRI showed clear lesions?” or “How might my own beliefs about mental health be influencing how I talk about FND?” can bring hidden assumptions to light. Supervisors and senior clinicians can model non-stigmatizing attitudes by explicitly acknowledging that FND can evoke complex reactions and by demonstrating curiosity rather than judgment in their own consultations.
Involving patients and people with lived experience in service design and professional education is another powerful strategy. Invited speakers with FND can share how certain words, gestures, or decisions affected their sense of being believed and their willingness to engage with care. Their narratives often highlight small but meaningful changes—such as a clinician maintaining eye contact, explicitly validating that the symptoms are not under voluntary control, or acknowledging past negative experiences—that transformed their perception of the health system. Including such voices in grand rounds, workshops, and curriculum development brings authenticity to training and reinforces that reducing stigma is not just an abstract ethical goal but a practical necessity for effective care.
Addressing structural stigma also requires looking at how services are organized and funded. When FND clinics are under-resourced, waitlists are long, or referrals are difficult to obtain, patients may feel their condition is not important enough to merit dedicated care. Health services can advocate internally for resources by highlighting the prevalence of FND, its contribution to emergency visits and hospital admissions, and the potential for cost savings through coordinated, evidence-based management. Presenting data on improved outcomes and reduced health care utilization after specialized interventions can help decision-makers see investment in FND services as both clinically and economically sensible. As services grow, they can in turn provide more education and support to generalist clinicians, spreading stigma-reducing practices more widely.
Integrating public awareness and advocacy efforts into clinical practice helps shift the broader narrative that shapes what happens in the consultation room. Clinicians can contribute to accurate media coverage by agreeing to interviews, providing expert commentary, or partnering with patient organizations to develop campaigns that highlight FND as a real, treatable condition. Within their own institutions, they can organize awareness days, poster campaigns, or lunchtime talks that feature up-to-date information and patient stories. These activities normalize FND alongside other neurological disorders and create an environment in which respectful, informed care is expected. When people with FND encounter a health system where staff are knowledgeable, communication is clear, and stigma is actively challenged, the path toward diagnosis, treatment, and recovery becomes more navigable and less isolating.
Improving patient and caregiver health literacy
Improving health literacy for people with functional neurological disorder and their caregivers starts with making information about the condition clear, consistent, and accessible. Many individuals first encounter the term only after months or years of unexplained symptoms, and they may already have absorbed stigma or confusion from prior encounters. Offering a straightforward explanation that FND is a disorder of nervous system function, not structure, helps anchor understanding. Describing how symptoms emerge from changes in brain networks—rather than from conscious choice or character flaws—reframes the experience in a medically valid way. When patients and families can place their symptoms within a coherent model, they are better equipped to make sense of daily fluctuations, participate in treatment, and resist messages that minimize or dismiss their condition.
Plain language is central to effective communication. Technical phrases such as “functional symptoms,” “conversion disorder,” or “psychogenic” can be unfamiliar or alarming if left unexplained. Clinicians and educators can translate these ideas into everyday terms: for example, “Your brain is working, but some of the automatic control systems are stuck in an unhelpful pattern, like a software glitch rather than a hardware break.” Visual metaphors—traffic jams in brain pathways, glitching software, or a misfiring circuit breaker—often resonate more than abstract neuroscientific descriptions. When complex concepts are presented simply, without oversimplifying or blaming, health literacy improves and people feel more confident asking questions instead of pretending to understand.
Written materials tailored to different learning styles and literacy levels are essential tools for reinforcing verbal explanations. Handouts, booklets, or emailed summaries can review key points about what FND is, how it is diagnosed, and what kinds of treatments are available. These resources should use short sentences, clear headings, and examples drawn from everyday life, such as how stress, fatigue, or changes in attention might influence symptom patterns. Including diagrams of the brain and nervous system, timelines showing how recovery may unfold, and checklists for tracking symptoms or triggers can make information more concrete. Providing materials in multiple languages and formats—such as large print, audio recordings, or simplified versions—ensures that people with varying educational backgrounds and cognitive capacities can still access the information they need.
Digital tools can expand access to reliable information and support self-management. Clinic websites, patient portals, and dedicated FND platforms can host videos, infographics, and interactive modules that explain core concepts step by step. Short videos in which clinicians and people with lived experience describe FND in accessible language can be especially powerful, countering stigma and offering validation. Apps or online programs may guide users through breathing exercises, grounding techniques, pacing strategies, and movement retraining, while also explaining why these skills matter in terms of brain function. Linking digital resources to credible professional bodies or recognized advocacy organizations helps distinguish them from unverified information found on social media or commercial sites promoting unproven cures.
Caregivers—family members, partners, and close friends—need targeted education as well. Their understanding of FND strongly influences day-to-day management, emotional climate, and adherence to treatment. Structured sessions that invite caregivers to learn alongside the patient can address common questions: whether symptoms are under voluntary control, how to respond during a functional seizure, when to encourage activity versus rest, and how to balance support with fostering independence. Providing caregivers with their own written materials, support groups, or online forums can reduce isolation and prevent misunderstandings that arise when people try to interpret complex symptoms without guidance.
Teaching practical skills is a core component of building health literacy, not an optional extra. Understanding that FND involves disrupted patterns in attention, movement, and sensation is only the first step; patients and caregivers also need concrete strategies to influence these patterns. Educational sessions can cover pacing of activities, sleep hygiene, basic pain management principles, and techniques for managing triggers such as noise, light, or emotional stress. Rehabilitation professionals can demonstrate how focusing attention in specific ways, changing posture, or using external cues can reduce certain symptoms. When people see that informed actions can alter their experience—however modestly at first—their sense of agency grows and hopelessness diminishes.
Interactive teaching methods are often more effective than passive information delivery. Instead of only handing out leaflets or giving a one-time lecture, clinicians can invite patients and caregivers to explain back what they have heard, using their own words. Questions such as, “How would you describe FND to a friend?” or “What do you think is happening in your body during these episodes?” reveal misunderstandings that may not surface otherwise. Group programs, whether in person or online, can combine short educational talks with discussions, role-plays, and problem-solving exercises. Participants can share strategies that worked for them, normalize difficulties, and learn from each other’s experiences. This collaborative approach not only supports health literacy but also reduces internalized stigma by demonstrating that others face similar challenges.
Addressing emotional responses to the diagnosis is another crucial element. Some people feel relief at finally having a name for their symptoms, while others experience anger, shame, or disbelief, especially if they associate FND with past messages that their problems were “all in their head.” Education efforts should acknowledge these reactions explicitly rather than rushing past them. Clinicians can frame FND as a condition that sits at the intersection of brain, body, and life experiences—neither “just psychological” nor purely mechanical—and reassure patients that having mixed feelings about the diagnosis is common. Providing space to process these emotions, with support from mental health professionals when needed, helps people move from confusion toward active engagement in treatment.
Cultural and linguistic considerations must be built into any health literacy initiative. Beliefs about illness, mental health, and disability vary widely, and a one-size-fits-all explanation may not resonate with everyone. In some cultures, discussing mental health openly is difficult, and symptoms are more easily understood through bodily or spiritual frameworks. Collaborating with cultural mediators, interpreters, community leaders, or faith-based organizations can help adapt explanations of FND to local perspectives while maintaining scientific accuracy. Translated materials should be culturally adapted, not just directly converted word for word, to ensure that metaphors, examples, and terms make sense in context. Involving people from diverse backgrounds in the development and review of educational content reduces the risk of unintentionally reinforcing stigma or misunderstanding.
Building strong communication channels between clinicians and patients supports ongoing learning rather than treating education as a single event. Offering scheduled follow-up appointments focused specifically on questions, checking understanding, and revising management plans allows information to be revisited as circumstances change. Secure messaging through patient portals, telephone check-ins, or nurse-led advice lines can provide timely clarification when new issues arise. Encouraging patients and caregivers to keep a notebook or digital log of questions, symptoms, and observations helps structure these conversations and fosters a sense of partnership. When people know they can bring uncertainties back to the team, they are less likely to turn solely to unreliable sources or to disengage from care.
Addressing misinformation directly is an important part of health literacy work. Many patients encounter online claims that FND is not a real condition, that it is purely a sign of personal weakness, or that it can only be cured by one specific, often expensive, intervention. Rather than dismissing these sources outright, clinicians can invite open discussion: “What have you read or heard about FND? What made sense to you, and what worried you?” This creates an opportunity to compare information with current evidence, explain why certain treatments are not recommended, and validate the understandable desire to find quick solutions. Teaching basic skills for evaluating health information—such as checking for reputable authors, references, and conflicts of interest—equips patients and caregivers to navigate the digital landscape more safely.
Group-based education programs can efficiently reach larger numbers of patients and caregivers while fostering peer support. These programs might include a series of sessions covering topics like the neuroscience of FND, symptom management, rehabilitation principles, mental health and coping strategies, and navigating work or school. Having different professionals lead different parts—a neurologist, psychologist, physiotherapist, occupational therapist, and social worker—underscores that FND is a multidisciplinary issue. Participants can share experiences, ask questions in a supportive environment, and learn how others have handled common challenges, such as explaining the condition to employers or teachers. Observing peers who have made progress can challenge beliefs that improvement is impossible and provide realistic hope.
Health literacy efforts also need to address the practical aspects of living with FND. Educational content can cover legal rights and accommodations at work or school, strategies for communicating with employers or educators, and tips for planning daily routines around fluctuating symptoms. Social workers or patient advocates can help explain disability benefits, transportation options, and community resources. Providing sample letters, checklists, or templates for workplace discussions reduces the burden on patients and caregivers who may feel overwhelmed by the need to advocate for themselves. When people understand both their medical condition and the systems around them, they are better equipped to secure the support they need.
Training clinicians in communication techniques specific to FND is itself a form of health literacy intervention. When professionals are confident in how to explain the diagnosis, address questions about prognosis, and respond to skepticism, they can create a more trusting environment. Brief, structured communication frameworks—such as starting with validation of symptoms, naming the diagnosis clearly, outlining the positive signs that support it, and then describing treatment options—can be practiced in workshops or supervision sessions. Improving clinician skills in this area pays dividends for patients and caregivers, who receive clearer, more consistent information and are less likely to leave appointments confused or distressed.
Partnerships with patient organizations and advocacy groups play an important role in expanding educational reach beyond the clinic. These groups often create brochures, videos, webinars, and peer-led programs that complement professional care. Clinicians can recommend vetted organizations, participate in joint educational events, or contribute to the development of materials to ensure they reflect up-to-date evidence. Advocacy groups, in turn, bring lived experience perspectives that highlight what information patients and caregivers find most useful in real life. This collaboration helps align messages across different platforms and reduces the risk of mixed or contradictory information, which can otherwise undermine trust and health literacy.
Public awareness campaigns indirectly strengthen individual health literacy by changing the broader conversation around FND. When accurate information appears in mainstream media, social networks, or community events, people are more likely to encounter the term before they or someone close to them is affected. Campaigns that emphasize FND as a common, legitimate neurological condition—and that feature stories of people who have learned to manage or improve their symptoms—counteract harmful stereotypes. As public understanding grows, patients and caregivers may find it easier to explain the condition to others, experience less stigma, and encounter more supportive responses from schools, workplaces, and social circles.
Evaluating the impact of health literacy initiatives helps refine and sustain them. Simple measures such as pre- and post-session questionnaires, feedback forms, and follow-up interviews can reveal whether participants feel more confident in their understanding of FND, whether they can explain the condition to others, and whether they are using new skills in daily life. Tracking outcomes like appointment attendance, adherence to rehabilitation programs, or reduced emergency visits over time can show how improved understanding translates into behavior and health. Using this information to adjust content, format, and delivery methods keeps education responsive to real needs and ensures that efforts to improve patient and caregiver health literacy remain an integral part of high-quality FND care.
Collaborative approaches to advocacy and education
Collaborative efforts that bring together patients, families, clinicians, researchers, and community organizations are central to transforming how functional neurological disorder is understood and addressed. No single group can tackle the intertwined challenges of stigma, limited health literacy, and fragmented services on its own. When stakeholders work in partnership, they can align messages, pool resources, and create a more coherent ecosystem of care and information. This collaboration makes it more likely that people with FND will encounter consistent explanations and supportive responses across settings—from the clinic to the workplace, from schools to social services.
Partnerships between clinical services and patient-led organizations are a cornerstone of effective advocacy and education. Clinicians bring expertise in diagnosis, treatment, and research, while people with lived experience contribute firsthand knowledge of what it feels like to navigate symptoms, health systems, and social reactions. When these perspectives are combined, educational materials and outreach efforts become more relevant and credible. For example, a neurologist and a patient advocate might co-develop a leaflet explaining FND, ensuring the medical information is accurate while the tone and language reflect what patients find validating and understandable. Jointly hosted information sessions—whether in hospitals, community centers, or online—signal that professionals and patients are on the same team, challenging the isolation that stigma often creates.
Interdisciplinary professional networks help standardize knowledge and reduce inconsistencies in communication. Regional or national FND working groups can include neurologists, psychiatrists, psychologists, physiotherapists, occupational therapists, speech and language therapists, nurses, and social workers who meet regularly to share cases, guidelines, and research updates. These networks can produce consensus statements on best practices for diagnosis and management, which are then disseminated through professional societies and conferences. When clinicians across specialties receive aligned guidance, patients are less likely to encounter conflicting explanations or encounter providers who dismiss the diagnosis. Over time, such collaboration can shift norms within health systems so that FND is recognized as a routine part of care rather than an outlier.
Formal partnerships with medical education institutions are another powerful avenue for change. Universities and training programs can invite patient organizations to co-design curricula that incorporate both scientific evidence and lived experience. Joint lectures, panel discussions, and simulated patient encounters can expose students and trainees to realistic scenarios involving FND, including the emotional and ethical challenges that may arise. When advocacy groups help shape these learning experiences, future clinicians are more likely to graduate with nuanced, respectful understandings of FND and practical skills in explanation and shared decision-making. Embedding this content early in training reduces the likelihood that outdated, stigmatizing ideas will be perpetuated across generations of health professionals.
Co-created public awareness campaigns amplify these educational efforts beyond clinical and academic settings. Media projects that feature clinicians, researchers, and people with FND speaking together are particularly effective at countering stereotypes. Short documentaries, podcasts, newspaper articles, or social media campaigns can show how FND affects daily life, highlight that symptoms are real and involuntary, and explain that recovery often involves active rehabilitation. When campaigns are developed in collaboration with communications experts, disability organizations, and community groups, they can reach broader and more diverse audiences. Aligning the core messages across all these platforms reduces confusion and helps ensure that people hearing about FND for the first time encounter a consistent, nonjudgmental narrative.
Schools and workplaces are key environments where collaborative advocacy can reduce stigma and support participation. Health professionals and patient organizations can work together to create guidance documents for educators, school counselors, human resources departments, and occupational health teams. These materials can explain how FND might present in students or employees—such as episodes of functional seizures, motor symptoms, or cognitive difficulties—and outline reasonable adjustments like flexible schedules, rest breaks, modified physical education, or temporary job modifications. Offering joint training sessions for school staff or employers, where a clinician explains the medical aspects and a person with FND shares personal experience, fosters empathy and practical understanding. This collaboration can prevent misinterpretations of symptoms as behavioral problems or lack of motivation.
Community health initiatives provide another setting for joint educational efforts. Primary care clinics, public health departments, and community centers can host information days or workshops on neurological and mental health conditions that include FND alongside more familiar diagnoses. Involving local patient leaders in planning and delivering these events helps ensure that the content resonates with the cultural context and addresses local barriers to care. Collaborative outreach programs can be tailored to specific groups—such as youth, older adults, or immigrant communities—incorporating interpreters, cultural mediators, and community advocates. This shared work can bridge gaps between specialist care and community resources, making it easier for people with FND to find knowledgeable support close to home.
Online platforms are especially suited to collaborative advocacy and education. Multidisciplinary teams and patient groups can co-manage websites, forums, or social media channels that provide vetted information, answer frequently asked questions, and share stories of coping and recovery. Moderated online communities, supported by both professionals and trained peer volunteers, can offer safe spaces where people with FND and caregivers exchange experiences, ask questions, and access reliable resources. Clear guidelines and joint moderation help maintain respectful dialogue and reduce the spread of misinformation. These virtual collaborations can reach individuals who are geographically isolated, unable to travel, or hesitant to seek in-person support due to stigma.
Research partnerships that include people with FND as co-investigators or advisors strengthen both the scientific and educational landscape. Collaborative research boards or advisory panels can help set priorities that reflect real-world needs, such as studying the impact of stigma, evaluating accessible rehabilitation models, or developing culturally adapted educational tools. Patients can assist in designing questionnaires, reviewing consent materials, and interpreting results in ways that make sense to the community. When research findings are translated into plain-language summaries co-written by researchers and patient partners, they become powerful tools for both advocacy and health literacy, demonstrating that FND is an active area of scientific inquiry rather than a neglected or mysterious condition.
Joint policy and systems-level advocacy is crucial for addressing structural barriers. Health professionals, patient organizations, and allies from disability rights and mental health advocacy groups can collaborate to present unified messages to policymakers, insurers, and health system leaders. Together, they can highlight the prevalence and impact of FND, the costs of delayed or fragmented care, and the benefits of funding multidisciplinary clinics, rehabilitation programs, and professional training. Co-authored policy briefs, testimony at legislative hearings, and meetings with health authorities can make a compelling case for including FND in national neurological and mental health strategies. Such coalitions carry more weight than isolated voices, increasing the likelihood that FND receives sustained attention and resources.
Collaboration with emergency services and acute care providers is particularly important given how often people with FND present in crisis. Joint initiatives can bring neurologists, emergency physicians, nurses, paramedics, and patient educators together to design protocols, training sessions, and quick-reference tools. These materials can explain how to recognize functional seizures or motor symptoms, when to pursue urgent investigations, and how to talk with patients and families in ways that validate symptoms while avoiding unnecessary interventions. Involving people with lived experience in these training sessions helps emergency staff understand how language, tone, and body language can either intensify or alleviate distress in high-pressure situations.
International collaboration adds another layer of strength to advocacy and education. FND-focused organizations and expert groups across different countries can share guidelines, educational resources, research findings, and campaign strategies. Joint conferences, webinars, and online training modules can reach global audiences, particularly in regions where local expertise is limited. Harmonizing terminology and key messages across borders helps reduce confusion and facilitates cross-country research and service development. International patient networks can also support individuals in countries with few local resources, offering peer support and information that might otherwise be inaccessible.
Co-developing training materials for health professionals is a practical way to embed collaboration into routine practice. Patient organizations, academic centers, and professional societies can work together to create modules on diagnosis, communication, and management of FND that are used in continuing education courses, residency programs, and online learning platforms. Incorporating video clips of patient interviews, jointly scripted case scenarios, and reflection exercises helps trainees grapple with the real-world complexities of care. When these materials explicitly address stigma, power dynamics, and the importance of collaborative communication, they contribute not only to clinical competence but also to a culture of respect and partnership.
Engaging with broader disability and mental health movements helps situate FND within a wider conversation about rights, inclusion, and equity. Joint campaigns with organizations representing people with epilepsy, chronic pain, movement disorders, or psychiatric conditions can highlight shared challenges, such as being disbelieved, facing employment discrimination, or struggling to access appropriate care. Collaborative events—such as awareness walks, panel discussions, or policy roundtables—can feature FND alongside other conditions, emphasizing common goals rather than competition for limited attention. This solidarity broadens the base of support for reforms that benefit many groups, including improvements in accessibility, anti-stigma legislation, and investment in integrated care models.
Sustainable collaboration requires clear structures, shared goals, and open lines of communication. Formal agreements—such as memoranda of understanding between hospitals and patient organizations, or steering committees that include representatives from multiple stakeholder groups—can clarify roles, expectations, and decision-making processes. Regular meetings and feedback mechanisms ensure that partnerships remain responsive to evolving needs rather than becoming symbolic or static. Evaluating joint initiatives through surveys, focus groups, and outcome data helps partners learn what works, identify gaps, and refine strategies over time. When collaboration is treated as an ongoing process rather than a one-time project, advocacy and education around FND can adapt and grow alongside emerging evidence and changing social contexts.
At every level, from local support groups to international networks, collaborative approaches make it more likely that people with FND encounter accurate information, respectful care, and meaningful opportunities to participate in decisions that affect their lives. By sharing responsibility for education, advocacy, and system change, stakeholders can create environments in which stigma is actively challenged, health literacy is nurtured, and the voices of those living with FND are central rather than peripheral to the conversation.
